TIDMALGW
RNS Number : 3897A
Alpha Growth PLC
02 February 2022
The information communicated within this announcement is deemed
to constitute inside information as stipulated under the Market
Abuse Regulation (EU) No. 596/2014 (as in force in the United
Kingdom pursuant to the European Union (Withdrawal) Act 2018). Upon
the publication of this announcement, this inside information is
now considered to be in the public domain
Alpha Growth Plc
("Alpha", or the "Company")
BlackOak Alpha Growth Fund managed by the Group continues its
Growth and Performance
Alpha Growth Plc (LSE: ALGW and OTCQB: ALPGF), a leading
financial services specialist in the growing longevity asset class,
is pleased to announce the results for the year-ended 31 December
2021 for its BlackOak Alpha Growth Fund (the "Fund") investing in
Senior Life Settlements ("SLS").
The Fund in 2021, has seen significant positive inflows of
investment, doubling its assets under management to $45 million and
achieving a compounded annual growth rate (CAGR) of 112% since
January 2020.
BOAGF AUM January 2020: $10m
BOAGF AUM January 2021: $22m
BOAGF AUM January 2022: $45m
On a net basis, the Fund produced a total return of 18.9%,
annualized 7.7% since inception in September 2019, and monthly
returns of 0.6%. The Fund has achieved positive returns in 27 out
of the 28 months it has been operational.
At 2021 year end the Fund owned 96 SLS with a total face value
of $79,626,819.83 and average life expectancy of 73 months. The
minimum is $100,000 and maximum face value is $5,000,000 with an
average face value of $829,446.04.
The Company continues to actively market the Fund to registered
investment advisors in the US and supplements this direct outreach
by showcasing the Fund at virtual events.
Danny Swick, COO and co-GP of the Fund stated "We continue to go
from strength to strength and have received a very positive
reception by investors that look for consistent and uncorrelated
returns and yield over multi-year periods. We continue to build our
portfolio of SLS into a well-diversified pool of policies and
remain focused on investing in quality SLS to meet our investment
objectives on behalf of our investors."
Gobind Sahney, Executive Chairman, added "The Alpha Growth team
continues to perform exceptionally well and have once again more
than doubled the size of the Fund over a 12 month period. During
this period, the Fund held 25% of its assets in cash, however as
the fund continues to grow and mature, we would expect this figure
to reduce to circa 15% - this will have a net positive impact on
future reported returns."
Gobind continued "Alpha continues to build on its business plan
of accreting assets under management and growing long term revenue
through its steady focus on the fund and insurance business
segments. Providence Life Assurance Company (Bermuda) Ltd continues
to perform well and is increasing its balance sheet assets. We have
successfully made a number of strategic advances in both business
segments recently and I look forward to updating our shareholders
when appropriate."
For more information, please visit www.algwplc.com or contact
the following:
Alpha Growth Plc +44 (0) 20 3959 8600
Gobind Sahney, Executive Chairman info@algwplc.com
BlackOak Alpha Growth Funds +1 949-326-9799
www.boagf.com
Arden Partners plc +44 (0) 20 7614 5900
Ruari McGirr / Alexandra Campbell-Harris
(Corporate Finance)
UK Investor Relations - Mark Treharne ir@algwplc.com
About Alpha Growth plc
Specialist in Longevity Assets
Alpha Growth plc is a financial advisory business providing
specialist consultancy, advisory, and supplementary services to
institutional and qualified investors globally in the multi-billion
dollar market of longevity assets. Building on its well-established
network, the Alpha Growth Group has a unique position in the
longevity asset services and investment business, as a listed
entity with global reach. The Group's strategy is to expand its
advisory and business services via acquisitions and joint ventures
in the UK and the US to attain commercial scale and provide
holistic solutions to alternative institutional investors who are
in need of specialised skills and unique access to deploy their
financial resource in longevity assets.
Longevity Assets and Non-correlation
As a longevity asset, it is non-correlated to the real estate,
equity capital and commodity markets. Its value is a function of
time because as time passes the value gets closer to the face value
of the policy. Hence creating a steady increase in the net asset
value of the investment. This makes it highly attractive to
investors wishing to counteract volatility within an investment
portfolio and add yield.
Note: The Company only advises on and manages Longevity Assets
that originate in the USA where the structured and life settlement
market is highly regulated.
Forward Looking Statements Disclaimer
Certain statements, beliefs and opinions in this document are
forward-looking, which reflect the Company's or, as appropriate,
the Company's directors' current expectations and projections about
future events. By their nature, forward-looking statements involve
a number of risks, uncertainties and assumptions that could cause
actual results or events to differ materially from those expressed
or implied by the forward-looking statements. These risks,
uncertainties and assumptions could adversely affect the outcome
and financial effects of the plans and events described herein.
Forward-looking statements contained in this document regarding
past trends or activities should not be taken as a representation
that such trends or activities will continue in the future. The
Company does not undertake any obligation to update or revise any
forward-looking statements, whether as a result of new information,
future events or otherwise. You should not place undue reliance on
forward- looking statements, which speak only as of the date of
this document. Readers should not treat the contents of this
document as advice relating to legal, taxation or investment
matters, and are to make their own assessments concerning these and
other consequences, including the merits of information and the
risks. Readers of this announcement are advised to conduct their
own due diligence and agree to be bound by the limitations of this
disclaimer.
Important Notice
The content of this announcement has not been approved by an
authorised person within the meaning of the Financial Services and
Markets Act 2000 (FSMA). This announcement has been issued by and
is the sole responsibility of the Company. The information in this
announcement is subject to change.
This announcement is not an offer of securities for sale into
the United States. The securities referred to herein have not been
and will not be registered under the U.S. Securities Act of 1933,
as amended (the Securities Act), and may not be offered or sold,
directly or indirectly, in or into the United States, except
pursuant to an applicable exemption from registration. No public
offering of securities is being made in the United States. This
announcement is not for release, publication or distribution,
directly or indirectly, in or into the United States, Australia,
Canada, the Republic of South Africa, Japan or any jurisdiction
where to do so might constitute a violation of local securities
laws or regulations (a Prohibited Jurisdiction). This announcement
and the information contained herein are not for release,
publication or distribution, directly or indirectly, to persons in
a Prohibited Jurisdiction unless permitted pursuant to an exemption
under the relevant local law or regulation in any such
jurisdiction.
About BlackOak Alpha Growth Fund
The Fund was established by two highly experienced longevity
asset management companies. The Fund invests in life settlements,
is a Cayman LP with a tax efficient Master/Feeder structure in an
open-ended format with quarterly redemptions. The Fund seeks to
provide well-diversified, non-correlated returns. The Fund aims to
achieve this objective through the acquisition of secondary and
tertiary Life Settlement policies that will be structured and
purchased to mitigate longevity risk and other investment and
business risks and where the Company's expertise can add value.
ENDS
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
MSCFFFLIFDILIIF
(END) Dow Jones Newswires
February 02, 2022 01:59 ET (06:59 GMT)
Alpha Growth (LSE:ALGW)
Historical Stock Chart
From Jun 2024 to Jul 2024
Alpha Growth (LSE:ALGW)
Historical Stock Chart
From Jul 2023 to Jul 2024
